{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:08:54Z","timestamp":1789391334534,"version":"build-2803163510"},"reference-count":13,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>We read with great interest the comments by Dr [...]<\/jats:p>","DOI":"10.3390\/jcm15187122","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:09:51Z","timestamp":1789387791000},"page":"7122","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to \u00c7evik et al. Comment on \u201cInghilleri, G.; Franchini, M. Hypophosphatemia in Patients Receiving Intravenous Iron Supplementation for Iron-Deficiency Anemia: A Narrative Review. J. Clin. Med. 2026, 15, 4748\u201d"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3502-1357","authenticated-orcid":false,"given":"Giovanni","family":"Inghilleri","sequence":"first","affiliation":[{"name":"Department of Immunohematology and Transfusion Medicine, Fatebenefratelli Sacco, 20157 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8795-0580","authenticated-orcid":false,"given":"Massimo","family":"Franchini","sequence":"additional","affiliation":[{"name":"Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, 46100 Mantua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"#cr-split#-ref_1.1","unstructured":"\u00c7evik, C., Oflas, N.D., Konur, K., Tazeg\u00fcl, G., Sevencan, N.\u00d6., and \u00d6zbilen, M. (2026). Comment on Inghilleri, G."},{"key":"#cr-split#-ref_1.2","doi-asserted-by":"crossref","unstructured":"Franchini, M. Hypophosphatemia in Patients Receiving Intravenous Iron Supplementation for Iron-Deficiency Anemia: A Narrative Review. J. Clin. Med. 2026, 15, 4748. J. Clin. Med., 15.","DOI":"10.3390\/jcm15124748"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Inghilleri, G., and Franchini, M. (2026). Hypophosphatemia in Patients Receiving Intravenous Iron Supplementation for Iron-Deficiency Anemia: A Narrative Review. J. Clin. Med., 15.","DOI":"10.3390\/jcm15124748"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2169\/naika.71.1566","article-title":"Osteomalacia Caused by Intravenous Administration of Saccharated Ferric Oxide for the Treatment of Iron Deficiency Anemia Associated with Nonspecific Multiple Ulcers of the Small Intestine: Report of Two Cases","volume":"71","author":"Okada","year":"1982","journal-title":"Nihon Naika Gakkai Zasshi"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/gutjnl-2022-327897","article-title":"Hypophosphataemia Following Ferric Derisomaltose and Ferric Carboxymaltose in Patients with Iron Deficiency Anaemia Due to Inflammatory Bowel Disease (PHOSPHARE-IBD): A Randomised Clinical Trial","volume":"72","author":"Zoller","year":"2023","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/14740338.2021.1912010","article-title":"Newer Formulations of Intravenous Iron: A Review of Their Chemistry and Key Safety Aspects\u2014Hypersensitivity, Hypophosphatemia, and Cardiovascular Safety","volume":"20","author":"Blumenstein","year":"2021","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ajh.27220","article-title":"Expert Consensus Guidelines: Intravenous Iron Uses, Formulations, Administration, and Management of Reactions","volume":"99","author":"Steinheiser","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Rosano, G., Ezekowitz, J., Nemeth, E., Ponikowski, P., Rauner, M., Seid, M., Spahn, D.R., Stein, J., Wish, J., and Mentz, R.J. (2025). Evaluating the Risk of Hypophosphatemia with Ferric Carboxymaltose and the Recommended Approaches for Management: A Consensus Statement. J. Clin. Med., 14.","DOI":"10.3390\/jcm14144861"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.bja.2026.04.073","article-title":"Intravenous Iron Administration and Management of Adverse Events: A Systematic Review and Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis Consensus Recommendations","volume":"137","author":"Kranke","year":"2026","journal-title":"Br. J. Anaesth."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41574-022-00662-x","article-title":"Interdisciplinary Management of FGF23-Related Phosphate Wasting Syndromes: A Consensus Statement on the Evaluation, Diagnosis and Care of Patients with X-Linked Hypophosphataemia","volume":"18","author":"Trombetti","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_11","first-page":"e96256","article-title":"Calcitriol as a Therapeutic Strategy for Ferric Carboxymaltose\u2013Induced Hypophosphatemia","volume":"17","author":"Patel","year":"2025","journal-title":"Cureus"},{"key":"ref_12","first-page":"ziae139","article-title":"In-Depth Clinical Characterization of Intravenous Iron Infusion-Induced Hypophosphatemic Osteomalacia and Its Resolution","volume":"9","author":"Grambeck","year":"2025","journal-title":"JBMR Plus"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7122\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:52:03Z","timestamp":1789390323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":13,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15187122"],"URL":"https:\/\/doi.org\/10.3390\/jcm15187122","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}